www.retrovirology.com

Table 1
*Integration sites of tumors assayed for Pvt1* exon 1 transcript, and for Pvt1-encoded miRNA expression**
#	Tumor	Location	Orientation

1	593S	chr15:61860693	T+G+
2	1919S	chr15:61866476	T+G+
3	194S	chr15:61866608	T+G+
4	1139S	chr15:61866868	T+G+
5	1963S	chr15:61867056	T+G+
6	3404S	chr15:61867131	T+G+
7	1744S	chr15:61867205	T+G+
8	244S	chr15:61867333	T+G+
9	560S	chr15:61867464	T+G+
10	1052S	chr15:61867915	G+T+
11	672S	chr15:61868051	G+T+
12	1813S	chr15:61868173	G+T+
13	955S	chr15:61868438	G+T-
14	763S	chr15:61868296	G+T+
15	1754S	chr15:61868379	G+T+
16	1182S	chr15:61868500	G+T+
17	1572S	chr15:61868585	G+T+
18	1890S	chr15:61868694	G+T+
19	1888S	chr15:61869059	G+T-
20	1190S	chr15:61868969	G+T+
21	504S	chr15:61869211	G+T+
22	2105S	chr15:61869357	G+T+
23	1910S	chr15:61870240	G+T+
24	549S	chr15:61874317	G+T+
25	3005S	chr15:61884560	G+T+
26	1437S	chr15:61893983	G+T+
27	455S	chr15:61909406	G+T+
28	2262S	chr15:61922370	G+T+
31	2062T	chr15:61988152	G+T+
32	1784S	chr15:61995200	G+T+
33	1551S	chr15:61996855	G+T+
34	3269T	chr15:61997744	G+T+
35	1309S	chr15:61998706	G+T+
36	1719S	chr15:62041370	G+T-
37	652T	chr15:62041573	G+T+
38	3155S	chr15:62042340	G+T+
39	133S	chr15:62043246	G+T+
40	1820S	chr15:62062642	G+T+
41	1187S	chr15:62285362	G+T+
42	1938T	chr15:62286594	G+T+
43	674S	chr15:62287322	G+T+
44	1907S	chr15:62288987	G+T+
45	1717T	chr15:62290852	G+T+
46	1959S	chr15:62524605	G+T+
C2	1855S	no Pvt1 integration site
C3	3252T	no Pvt1 integration site
C4	3413T	no Pvt1 integration site
C5	3421S	no Pvt1 integration site
C6	1463S	no Pvt1 integration site
C7	1967S	no Pvt1 integration site
C8	14845S	no Pvt1 integration site
C9	1278S	no Pvt1 integration site
C10	1065S	no Pvt1 integration site
Transcript:	AK030859	chr15:61867667–61870735	G+

Sites as defined by mm8 version of genome. Orientation, either "+" or "-", of the proviral insert (tag, denoted as T) relative to the direction of the genome display, and to the Pvt1 transcript ("gene", denoted as G, here always G+).
Beck-Engeser et al. Retrovirology 2008 5:4 doi:10.1186/1742-4690-5-4

Table 1